Full Length Research Paper
References
|
Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H (1996). Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob. Agents Chemother. 40:1938-1940. |
|
|
Abdulgader SMA, Shittu AO, MP, Kaba M (2015). Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review. Front. Microbiol. 6:348. |
|
|
Archer GL, Niemeyer DM (1994). Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol. 2:343-347. |
|
|
Aubry-Damon H, Soussy CJ, Courvalin P (1998). Characterization of Mutations in therpoB Gene That Confer Rifampin Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42: 2590-2594. |
|
|
Casey AL, Lambert PA, Elliott TSJ (2007). Staphylococci. Int. J. Antimicrob. Agents 29: S23-S32. |
|
|
Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK (2003). Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347. |
|
|
CLSI (2002). Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. CLSI document M100-S12. Wayne, PA: Clinical and Laboratory Standards Institute. |
|
|
CLSI (2015). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute. |
|
|
Daum RS, Gupta S, Sabbagh R, Milewski WM (1992). Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166: 1066-1072. |
|
|
Donnelly JP, Voss A, Witte W, Murray BE (1996). Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? J. Antimicrob. Chemother. 37: 389-392. |
|
|
Drees M, Gerber JS, Morgan DJ, Lee Grace M (2016). Research methods in healthcare epidemiology and antimicrobial stewardship: Use of administrative and surveillance databases. Infect. Control Hosp. Epidemiol. 37:1278-1287. |
|
|
Economou V, Gousia P (2015). Agriculture and food animals as a source of antimicrobial-resistant bacteria. Infect. Drug Resist. 8: 49-61. |
|
|
Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG (2000). Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus multilocus sequence typing for characterization of methicillin- resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Bacteriol. 38:1008-1015. |
|
|
Falagas ME, Karageorgopoulos DE, Leptidis J, Korbila LP (2013). MRSA in Africa: Filling the global map of antimicrobial resistance (K Becker, Ed.). PLoS One 8:e68024. |
|
|
Farr BM (2004). Prevention and control of methicillin-resistant Staphylococcus aureus infections. Curr. Opin. Infect. Dis. 17: 317-322. |
|
|
Fluit AC, Visser MR, Schmitz FJ (2001). Molecular Detection of antimicrobial resistance. Clin. Microbiol. Rev. 14:836-871. |
|
|
Gad GFM, Abd El-Ghafar AEGF, El-Domany RAA, Hashem ZS (2010). Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases. Braz. J. Microbiol. 41: 333-344. |
|
|
Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I (1997). Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673. |
|
|
Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136. |
|
|
Indalo AA (1997). Antibiotic sale behaviour in Nairobi: a contributing factor to antimicrobial drug resistance. East Afr. Med. J. 74: 171-173. |
|
|
Johnson AP, Henwood C, Mushtaq S, James D, Warner M, Livermore DM, ICU Study Group (2003). Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents. J. Hosp. Infect. 54:179-187. |
|
|
Kesah C, Redjeb S Ben, Odugbemi TO, Boye CSB, Dosso M, Ndinya AJO, Koulla-Shiro S, Benbachir M, Rahal K, Borg M (2003). Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin. Microbiol. Infect. 9: 153-156. |
|
|
Leclercq R, Courvalin P (1997). Resistance to glycopeptides in enterococci. Clin. Infect. Dis. 24:545-554. |
|
|
Lee HS, Loh YX, Lee JJ, Liu CS, Chu C (2015). Antimicrobial consumption and resistance in five Gram-negative bacterial species in a hospital from 2003 to 2011. J. Microbiol. Immunol. Infect. 48:647-654. |
|
|
Lee JH (2003). Methicillin (oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl. Environ. Microbiol. 69: 6489-6494. |
|
|
Loir Y Le, Baron F, Gautier M (2003). Staphylococcus aureus and food poisoning. Genet. Mol. Res. 2:63-76. |
|
|
Lowy FD (2003). Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 111: 1265-1273. |
|
|
Marais E, Aithma N, Perovic O, Oosthuysen WF, Musenge E, Dusé AG (2009). Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. South Afr. Med. J. 99: 170-173. |
|
|
Mitsuyama J, Yamada H, Maehana J, Fukuda Y, Kurose S, Minami S, Todo Y, Watanabe Y, Narita H (1997). Characteristics of quinolone-induced small colony variants in Staphylococcus aureus. J. Antimicrob. Chemother. 39:697-705. |
|
|
Monaco M, Pimentel de Araujo F, Cruciani M, Coccia EM, Pantosti A (2016). Worldwide epidemiology and antibiotic resistance of Staphylococcus aureus. Curr. Top. Microbiol. Immunol. 358: 3-32. |
|
|
Mulvey MR, Chui L, Ismail J, Louie L, Murphy C, Chang N, Alfa M, Canadian Committee for the Standardization of Molecular Methods (2001). Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 39: 3481-3485. |
|
|
Muthotho James N, Waiyaki Peter G, Mbalu Michael, Wairugu Anne, Mwanthi Beth, Odongo Ben (1995). Control of spread of methicillin resistant Staphylococcus aureus (MRSA) in Burns Units. Afr. J. Health Sci. 2:232-235. |
|
|
Noble WC, Virani Z, Cree RG (1992). Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198. |
|
|
Palazzo ICV, Araujo MLC, Darini ALC (2005). First Report of vancomycin-resistant Staphylococci isolated from healthy carriers in Brazil. J. Clin. Microbiol. 43:179-185. |
|
|
Reynolds R, Potz N, Colman M, Williams A, Livermore D, MacGowan A (2004). Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: The BSAC Bacteraemia Resistance Surveillance Programme. J. Antimicrob. Chemother. 53: 1018-1032. |
|
|
Roess AA, Winch PJ, Ali NA, Akhter A, Afroz D, El Arifeen S, Darmstadt GL, Baqui AH, Group for the Bangladesh PROJAHNMO Study (2013). Animal Husbandry Practices in Rural Bangladesh: Potential Risk Factors for Antimicrobial Drug Resistance and Emerging Diseases. Am. J. Trop. Med. Hyg. 89: 965-970. |
|
|
Shakibaie MR, Mansouri S, Hakak S (2002). Plasmid pattern of antibiotic resistance in beta-lactamase producing Staphylococcus aureus strains isolated from hospitals in Kerman, Iran. Am. J. Med. Sci 27:80-83. |
|
|
Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999). The Development of Vancomycin Resistance in a Patient with Methicillin-Resistant Staphylococcus aureus infection. N. Engl. J. Med. 340: 517-523. |
|
|
Sieradzki K, Tomasz A (1997). Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566. |
|
|
Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, Clark NC, Hiramatsu K (1998). Characterization of Staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027. |
|
|
Van den Bogaard AE, Mertens P, London NH, Stobberingh EE (1997). High prevalence of colonization with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame? J. Antimicrob. Chemother. 40:454-456. |
|
|
Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, Appelbaum PC, Chaitram J, Weigel LM, Jernigan J, McDougal LK, Tenover FC, Fridkin SK (2004). Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin. Infect. Dis. 38:1049-1055. |
|
|
Wielders CLC, Fluit AC, Brisse S, Verhoef J, Schmitz FJ (2002). mecA gene is widely disseminated in Staphylococcus aureus population. J. Clin. Microbiol. 40:3970-3975. |
|
|
Witte W (1997). Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba Found. Symp. 207:61-75. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
